| http://www.w3.org/ns/prov#value | - The following discussion and analysis of the results of operations and financial condition of Insys Therapeutics, Inc. for the years ended December 31, 2013 and 2012 should be read in conjunction with the consolidated financial statements and the notes thereto, and other financial information contained elsewhere in this Form 10-K. Overview We are a commercial-stage specialty pharmaceutical company
|
